^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma

Published date:
06/17/2021
Excerpt:
...a patient with PD-L1-negative and MCPyV-negative MCC who had disease progression following ECT experienced complete tumor regression with avelumab treatment…
DOI:
https://doi.org/10.3389/fonc.2021.628324